| 000 | 01904 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516101917.0 | ||
| 264 | 0 | _c20130809 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1948-7193 | ||
| 024 | 7 |
_a10.1021/cn100031t _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpeed, Nicole K | |
| 245 | 0 | 0 |
_aAkt-dependent and isoform-specific regulation of dopamine transporter cell surface expression. _h[electronic resource] |
| 260 |
_bACS chemical neuroscience _cJul 2010 |
||
| 300 |
_a476-81 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAllosteric Regulation |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Membrane _xenzymology |
| 650 | 0 | 4 |
_aCorpus Striatum _xcytology |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aDopamine Plasma Membrane Transport Proteins _xgenetics |
| 650 | 0 | 4 |
_aDopaminergic Neurons _xdrug effects |
| 650 | 0 | 4 |
_aHEK293 Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xphysiology |
| 650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aProtein Processing, Post-Translational |
| 650 | 0 | 4 |
_aProtein Transport _xphysiology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aMatthies, Heinrich J G | |
| 700 | 1 | _aKennedy, J Phillip | |
| 700 | 1 | _aVaughan, Roxanne A | |
| 700 | 1 | _aJavitch, Jonathan A | |
| 700 | 1 | _aRusso, Scott J | |
| 700 | 1 | _aLindsley, Craig W | |
| 700 | 1 | _aNiswender, Kevin | |
| 700 | 1 | _aGalli, Aurelio | |
| 773 | 0 |
_tACS chemical neuroscience _gvol. 1 _gno. 7 _gp. 476-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/cn100031t _zAvailable from publisher's website |
| 999 |
_c21931483 _d21931483 |
||